304 related articles for article (PubMed ID: 16189255)
1. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome.
Rosenfield RL; Devine N; Hunold JJ; Mauras N; Moshang T; Root AW
J Clin Endocrinol Metab; 2005 Dec; 90(12):6424-30. PubMed ID: 16189255
[TBL] [Abstract][Full Text] [Related]
2. Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome.
Davenport ML
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S91-7. PubMed ID: 16735135
[TBL] [Abstract][Full Text] [Related]
3. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group.
Chernausek SD; Attie KM; Cara JF; Rosenfeld RG; Frane J
J Clin Endocrinol Metab; 2000 Jul; 85(7):2439-45. PubMed ID: 10902791
[TBL] [Abstract][Full Text] [Related]
5. Optimizing estrogen replacement treatment in Turner syndrome.
Rosenfield RL; Perovic N; Devine N; Mauras N; Moshang T; Root AW; Sy JP
Pediatrics; 1998 Aug; 102(2 Pt 3):486-8. PubMed ID: 9685449
[TBL] [Abstract][Full Text] [Related]
6. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Massa GG; Rouwe CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1999 Dec; 84(12):4607-12. PubMed ID: 10599727
[TBL] [Abstract][Full Text] [Related]
7. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
[TBL] [Abstract][Full Text] [Related]
8. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome.
Reiter EO; Blethen SL; Baptista J; Price L
J Clin Endocrinol Metab; 2001 May; 86(5):1936-41. PubMed ID: 11344188
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
[TBL] [Abstract][Full Text] [Related]
10. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.
Quigley CA; Wan X; Garg S; Kowal K; Cutler GB; Ross JL
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1754-64. PubMed ID: 24762109
[TBL] [Abstract][Full Text] [Related]
11. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
[TBL] [Abstract][Full Text] [Related]
12. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
Cacciari E; Mazzanti L
J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
[TBL] [Abstract][Full Text] [Related]
13. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
[TBL] [Abstract][Full Text] [Related]
15. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
Binder G; Baur F; Schweizer R; Ranke MB
J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome.
Mauras N; Shulman D; Hsiang HY; Balagopal P; Welch S
J Clin Endocrinol Metab; 2007 Nov; 92(11):4154-60. PubMed ID: 17711924
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.
Davenport ML; Crowe BJ; Travers SH; Rubin K; Ross JL; Fechner PY; Gunther DF; Liu C; Geffner ME; Thrailkill K; Huseman C; Zagar AJ; Quigley CA
J Clin Endocrinol Metab; 2007 Sep; 92(9):3406-16. PubMed ID: 17595258
[TBL] [Abstract][Full Text] [Related]
18. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
Mauras N; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
[TBL] [Abstract][Full Text] [Related]
19. Final height in young women with Turner syndrome after GH therapy: an open controlled study.
Hochberg Z; Zadik Z
Eur J Endocrinol; 1999 Sep; 141(3):218-24. PubMed ID: 10474118
[TBL] [Abstract][Full Text] [Related]
20. Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD.
Hasegawa Y; Ariyasu D; Izawa M; Igaki-Miyamoto J; Fukuma M; Hatano M; Yagi H; Goto M
Endocr J; 2017 Feb; 64(2):221-227. PubMed ID: 27916781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
